Jefferies raised its price target on Buy-rated Opko Health (NYSE: OPK) from $8 to $9 on narrower FY12 net loss ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE